Table 3.
Median, mean, and range for the total clinical score by group and study period
| Study Period | G0a | K1a | G1a | K2a | G2a | K1, G1, K2, G2 |
|---|---|---|---|---|---|---|
| Group | Median, Mean (Range) | Median, Mean (Range) | Median, Mean (Range) | Median, Mean (Range) | Median, Mean (Range) | Median, Mean |
| Placebo | 13, 13.8 (5–31) | 14.5, 15.3 (2–29) | 12.5, 16.8 (8–36) | 14, 15.5 (3–33) | 13.5, 15.3 (4–34) | 58, 63 |
| Pheromone | 9.5, 12.8 (3–31) | 15, 15 (2–28) | 12, 12.3 (3–28) | 16, 16 (5–29) | 11, 13.2 (3–31) | 55.5, 56.5 |
| P value | 0.58 | 0.92 | 0.06 | 0.66 | 0.32 | 0.23 |
G#, group‐housed period number; K#, kennel‐housed period number. G1, G2: the 2, 2‐week group‐housing periods after placement of the diffusers in G0; K1, K2: the 2, 2‐week kenneled periods. The means and ranges are shown to demonstrate variation between the 6 kittens per group; the group medians are compared by Wilcoxon rank sum test. Statistical significance: P < 0.05.
a
n = 84 observations: 14 observations per 6 kittens per 2‐week study period per group.